These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1145115)

  • 41. Comparison of the sensitivity to agglutination and haemolysis by a high-titre cold antibody of the erythrocytes of normal subjects and of patients with a variety of blood diseases including paroxysmal nocturnal haemoglobinuria.
    LEWIS SM; DACIE JV; TILLS D
    Br J Haematol; 1961 Jan; 7():64-72. PubMed ID: 13761757
    [No Abstract]   [Full Text] [Related]  

  • 42. Paroxysmal nocturnal haemoglobinuria testing in blood transfusion laboratories: do they go with the flow?
    Whitby L; White J; Fletcher M; Whitby A; Milkins C; Barnett D
    Transfus Med; 2018 Dec; 28(6):451-456. PubMed ID: 28833743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole blood transfusion and paroxysmal nocturnal haemoglobinuria meet again: Minor incompatibility, major trouble.
    Laegreid IJ; Wilson T; Naess KH; Ernstsen SL; Schou V; Arsenovic MG
    Vox Sang; 2022 Nov; 117(11):1323-1326. PubMed ID: 36102159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paroxysmal nocturnal haemoglobinuria.
    McAllen PM; Roberts PD
    Proc R Soc Med; 1973 Nov; 66(11):1105-6. PubMed ID: 4777027
    [No Abstract]   [Full Text] [Related]  

  • 45. Production of in vitro lytic characteristics of paroxysmal nocturnal hemoglobinuria erythrocytes in normal erythrocytes.
    Kann HE; Mengel CE; Meriwether WD; Ebbert L
    Blood; 1968 Jul; 32(1):49-58. PubMed ID: 5658390
    [No Abstract]   [Full Text] [Related]  

  • 46. Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010.
    Nissen-Meyer LS; Tjønnfjord GE; Golebiowska E; Kjeldsen-Kragh J; Akkök ÇA
    Tidsskr Nor Laegeforen; 2015 Jun; 135(11):1039-43. PubMed ID: 26080779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
    Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
    J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
    Schmidt CQ; Harder MJ; Nichols EM; Hebecker M; Anliker M; Höchsmann B; Simmet T; Csincsi ÁI; Uzonyi B; Pappworth IY; Ricklin D; Lambris JD; Schrezenmeier H; Józsi M; Marchbank KJ
    Immunobiology; 2016 Apr; 221(4):503-11. PubMed ID: 26792457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RBC transfusions in paroxysmal nocturnal hemoglobinuria.
    Gockerman JP; Brouillard RP
    Arch Intern Med; 1977 Apr; 137(4):536-8. PubMed ID: 849085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [PNH--paroxysmal nocturnal hemoglobinuria. An old disease explained by new technology].
    Hast R
    Lakartidningen; 1997 Nov; 94(47):4323-6. PubMed ID: 9424527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.
    Weitz IC; Razavi P; Rochanda L; Zwicker J; Furie B; Manly D; Mackman N; Green R; Liebman HA
    Thromb Res; 2012 Sep; 130(3):361-8. PubMed ID: 22542362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH).
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Br J Haematol; 1989 Aug; 72(4):578-83. PubMed ID: 2775661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eculizumab for paroxysmal nocturnal haemoglobinuria.
    Parker C
    Lancet; 2009 Feb; 373(9665):759-67. PubMed ID: 19144399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New insights into paroxysmal nocturnal hemoglobinuria.
    Savage WJ; Brodsky RA
    Hematology; 2007 Oct; 12(5):371-6. PubMed ID: 17852463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iptacopan: First Approval.
    Syed YY
    Drugs; 2024 May; 84(5):599-606. PubMed ID: 38517653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe haemolysis and renal failure in a patient with paroxysmal nocturnal haemoglobinuria.
    Jackson GH; Noble RS; Maung ZT; Main J; Smith SR; Reid MM
    J Clin Pathol; 1992 Feb; 45(2):176-7. PubMed ID: 1541704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased hemolysis following administration of antioxidant-fermented papaya preparation (FPP) to a patient with PNH.
    Ghoti H; Rosenbaum H; Fibach E; Rachmilewitz EA
    Ann Hematol; 2010 Apr; 89(4):429-30. PubMed ID: 19756600
    [No Abstract]   [Full Text] [Related]  

  • 58. Membrane peroxidation and vitamin E.
    Mino M
    Acta Paediatr Jpn; 1971 Dec; 13(2):29-35. PubMed ID: 5004838
    [No Abstract]   [Full Text] [Related]  

  • 59. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.
    Iwanaga M; Furukawa K; Amenomori T; Mori H; Nakamura H; Fuchigami K; Kamihira S; Nakakuma H; Tomonaga M
    Br J Haematol; 1998 Jul; 102(2):465-74. PubMed ID: 9695961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An examination of complement proteins on membranes of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Burapakulsolsri N; Yuthavong Y; Wilairat P
    Br J Haematol; 1979 Mar; 41(3):393-8. PubMed ID: 427043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.